High tissue levels of PAI-1 and uPA also led to a shorter DFS and OS in gastric, lung and ovarian cancer (Brungs et al. 2017; Su et al. 2015; Kuhn et al. 1999). This evidence concerns the gene PLAU and ovarian cancer.